Contribution of morphine and morphine-6-glucuronide to respiratory depression in a child

Anaesthesia and Intensive Care

Volumn 40, Issue 5, 2012, Pages 867-870

  Hanam, J A ^a   Anderson, B J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Drugs; Metabolites; Morphine; Pharmacodynamics; Pharmacokinetics; Respiratory depression

Indexed keywords

CAPTOPRIL; FENTANYL; LABETALOL; MORPHINE; MORPHINE 6 GLUCURONIDE; NIFEDIPINE; NITROPRUSSIDE SODIUM;

ARTICLE; CASE REPORT; CHILD; CONGESTIVE HEART FAILURE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ENDOCRINE SURGERY; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY FAILURE; MALE; PARATHYROID RESECTION; PATIENT CONTROLLED ANALGESIA; RESPIRATION DEPRESSION; SCHOOL CHILD;

EID: 84866548873     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000516     Document Type: Article

References (15)

1. Lynn AM, Nespeca MK, Opheim KE, Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993; 77:695-701.
2. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NHG. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 2004; 92:208-217.
3. Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther 2007; 82:17-20.
4. Sam WJ, MacKey SC, Lotsch J, Drover DR. Morphine and its metabolites after patient-controlled analgesia: considerations for respiratory depression. J Clin Anesth 2011; 23:102-106.
5. Bolan EA, Tallarida RJ, Pasternak GW. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 2002; 303:557-562.
6. Pasternak GW. Preclinical pharmacology and opioid combinations. Pain Med 2012; 13 Suppl 1:S4-S11.
7. Dahan A, Romberg R, Teppema L, Sarton E, Bijl H, Olofsen E. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion. Anesthesiology 2004; 101:1201-1209.
8. Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modeling to analgesia. In: Foley KM, Inturrisi CE, eds. Advances in Pain Research and Therapy Opioid Analgesics in the Management of Clinical Pain. New York: Raven Press 1986. p. 441-452.
9. van Dorp ELA, Romberg R, Sarton E, Bovill JG, Dahan A. Morphine-6-glucuronide: morphine's successor for postoperative pain relief? Anesth Analg 2006; 102:1789-1797.
10. Bouwmeester NJ, van den Anker JN, Hop WCJ, Anand KJS, Tibboel D. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth 2003; 90:642-652.
11. Bray RJ, Beeton C, Hinton W, Seviour JA. Plasma morphine levels produced by continuous infusion in children. Anaesthesia 1986; 41:753-755.
12. Lynn AM, Opheim KE, Tyler DC. Morphine infusion after pediatric cardiac surgery. Crit Care Med 1984; 12:863-866.
13. Romberg R, Olofsen E, Sarton E, Teppema L, Dahan A. Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. Anesthesiology 2003; 99:788-798.
14. Lotsch J, Skarke C, Schmidt H, Grosch S, Geisslinger G. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Anesthesiology 2001; 95:1329-1338.
15. Anderson BJ. My child is unique; the pharmacokinetics are universal. Paediatr Anaesth 2012; 22:530-538.